Department of Dermatology

S2k-Leitlinie zur Diagnostik und Therapie des kutanen Lupus erythematodes – Teil 1: Klassifikation, Diagnostik, Prävention und Aktivitätsscores (2021) Worm M, Zidane M, Eisert L, Fischer-Betz R, Foeldvari I, Günther C, Iking-Konert C, et al. Journal article Patient-oriented Comparison of Systems Therapies for advanced Melanoma: a multicenter Cross-Sectional Study (2021) Thiem A, Mashhadiakbar P, Cussigh C, Hassel JC, Grimmelmann I, Gutzmer R, Schlaak M, et al. Conference contribution S2k guideline: Diagnosis and management of cutaneous lupus erythematosus - Part 1: Classification, diagnosis, prevention, activity scores (2021) Worm M, Zidane M, Eisert L, Fischer-Betz R, Foeldvari I, Günther C, Iking-Konert C, et al. Journal article Response to letter entitled: ‘Re: Hematological immune related adverse events after treatment with immune checkpoint inhibitors’ (2021) Heinzerling L, La Rosée P, Gutzmer R, Kramer R, Keller-Stanislawski B, Zierold S, Mentzer D Journal article Patch test informed consent form: position statement by European Academy of Dermatology and Venereology Task Force on Contact Dermatitis (2021) Balato A, Scala E, Ayala F, Bauer A, Crepy MN, Goncalo M, Johansen JD, et al. Journal article Trotz einer großen Auswahl wirksame Medikamente: Psoriatiker scheinen immer noch untertherapiert zu sein (2021) Pilz AC, Zink A, Schielein MC, Hell K, Romer K, Hillmann E, Bäumer D, et al. Journal article Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis (2021) Koch E, Petzold A, Wessely A, Dippel E, Gesierich A, Gutzmer R, Hassel JC, et al. Journal article Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases (2021) Zaremba A, Philip M, Hassel JC, Glutsch V, Fiocco Z, Loquai C, Rafei-Shamsabadi D, et al. Journal article Integrating patient data into skin cancer classification using convolutional neural networks: Systematic review (2021) Höhn J, Hekler A, Krieghoff-Henning E, Kather JN, Utikal JS, Meier F, Gellrich FF, et al. Journal article, Review article Risk Factors for Relapse after Intentional Discontinuation of Immune Checkpoint Inhibitors in Melanoma Patients (2021) Persa OD, Schatton K, Rübben A, Berking C, Erdmann M, Schlaak M, Mauch C, Steeb T Journal article